Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GJD2 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C1R - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MMP25 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
RASIP1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
ACTC1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Profile neighbors
KIR3DX1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GEO DataSets Gene Profile neighbors Chromosome neighbors
REST - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CELSR1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
BFSP1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
GNAO1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
EPHA3 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
HTR1A - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
CFHR4 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NCR1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NPAS3 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
NR6A1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
MOG - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
LYVE1 - beta-TrCP inhibition and androgen ablation effects on prostate cancer cell line LAPC4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on